**Company number: 02949804 Charity number: 1073453**
**Centre for Research and Implementation of Clinical Practice**
**(A company limited by guarantee)**
**Directors' report and financial statements**
**for the year ended 30 March 2025**
## **Centre for Research and Implementation of Clinical Practice (A company limited by guarantee)**
## **Contents**
||**Page**|
|---|---|
|Legal and administrative information|**1**|
|Trustees' (directors) report|**2 - 4**|
|Independent examiner's report|**5**|
|Statement of financial activities|**6**|
|Balance sheet|**7 - 8**|
|Notes to the financial statements|**9 - 11**|
## **Centre for Research and Implementation of Clinical Practice (A company limited by guarantee)**
## **Legal and administrative information**
|**Charity number**|1073453|
|---|---|
|**Company registration number**|02949804|
|**Registered office**|7-8 Ritz Parade|
||Western Avenue|
||London|
||W5 3RA|
|**Charity Trustees (directors)**|P J Franks|
||C J Moffatt|
||S G Murray|
||J A Stirling|
|**Secretary**|P J Franks|
|**Independent examiner**|Arvind Joshi FCA CTA DChA|
||Levy + Partners Limited|
||Chartered Accountants|
||7-8 Ritz Parade|
||Western Avenue|
||London|
||W5 3RA|
|**Bankers**|Barclays Bank plc|
||Fulham Broadway Branch|
||Hammersmith Business Centre Group|
||P O Box 738|
||London W6 9HY|
**Page 1**
## **Centre for Research and Implementation of Clinical Practice (A company limited by guarantee)**
## **Trustees' Report (incorporating the directors' report) for the year ended 30 March 2025**
The trustees, who are also directors of the charity for the purpose of the Companies Act 2006, present their report with the financial statements of the charitable company for the year ended 30 March 2025.
## **Principal activity and review**
The Centre for Research and Implementation of Clinical Practice (CRICP) is a private company limited by guarantee and accordingly does not have a share capital. It was incorporated on 18 July 1994. The company was registered as a charity on 22 January 1999. The charity is known informally as the Centre for Research (CRICP).
## **Structure, governance and management**
The company's governing document is the Memorandum and Articles of Association, as amended by a special resolution dated 22 November 2023.
## **Objectives and activities**
The company's objectives and activities are the evaluation and implementation of research based practice into the treatment of chronic wounds, including leg ulceration, pressure ulceration and lymphoedema, through research, education and audit.
## **Achievements and performance**
The company continues its work in lymphoedema and chronic wounds. The close partnership with the International Lymphoedema Framework (ILF) continues with the work expanding to take in new countries. Our publication policy may change in that there is a possibility that we will no longer be producing a third dedicated edition of Lymphatic Research & Biology, but this has yet to be finalised.
The Limprint database continues to offer us opportunities for new research, and Child Limprint is progressing well.
## **Financial review**
In the period under review the company returned a deficit on ordinary activities:
|Surplus on ordinary activities
Retained reserves brought forward
Retained reserves carried forward|**£**
3,535
553|
|---|---|
||4,088|
**Page 2**
## **Centre for Research and Implementation of Clinical Practice (A company limited by guarantee)**
## **Trustees' Report (incorporating the directors' report) for the year ended 30 March 2025**
## **Future developments**
The company's general income stream has become challenging as the regular income from our industry partners is no longer available. The company continues to offer support to health care providers and companies by developing research opportunities in the areas of wound care and lymphoedema. We continue to support AOTI in their work on venous leg ulceration and a new project on diabetic foot ulceration.
## **Public benefit**
The trustees confirm that they have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the charity's objectives and activities and in planning future activities.
The work undertaken by CRICP relates to the management of important health issues. To advance these areas, CRICP undertakes research with clinical partners to develop patient orientated approaches to describe those patients who suffer from these conditions, and to examine the potential benefits of the appropriate management according to their own health and quality of life, and the potential benefits to the health organisations who manage them.
It is the judgement of the trustees that activities in pursuit of the above objectives fully meet the public benefit test, which they have kept in mind in planning programmes for the charity.
## **Statement of trustees' responsibilities**
The trustees, who are also the directors of Centre for Research and Implementation of Clinical Practice for the purpose of company law, are responsible for preparing the Trustees' Report and the accounts in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure of the charitable company for that period. In preparing these financial statements, the trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in the Charities SORP;
- make judgments and estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the accounts; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.
The trustees are responsible for maintaining proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and to enable them to ensure that the accounts comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The charity trustees who served during the year and up to the date of this report are set out on page 1.
**Page 3**
## **Centre for Research and Implementation of Clinical Practice**
## **(A company limited by guarantee)**
## **Trustees' Report (incorporating the directors' report) for the year ended 30 March 2025**
## **Auditors**
Under an elective resolution dated 16 December 1994 it was resolved to dispense with the obligation to appoint auditors annually.
Under the provisions of the Companies Acts as the company is a small company an audit is no longer required. Messrs. Levy & Partners have signified their willingness to act as independent examiners.
This report was approved by the Board on 10 September 2025 and signed on its behalf by:
P J Franks **Trustee (Director)**
**Page 4**
## **Centre for Research and Implementation of Clinical Practice**
## **(A company limited by guarantee)**
## **Independent examiner's report to the trustees of Centre for Research and Implementation of Clinical Practice.**
I report to the charity trustees on my examination of the accounts of Centre for Research and Implementation of Clinical Practice (a company limited by guarantee) for the year ended 30 March 2025, as set out on pages 2 to 11.
## **Responsibilities and basis of report**
As the charity's trustees (who are also the directors of the company for the purposes of company law), you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ("the 2006 Act").
Having satisfied myself that the accounts of the Company are not required to be audited for this year under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ("the 2011 Act"). In carrying out my examination, I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
## **Independent examiner's statement**
I have completed my examination. I confirm that no material matters have come to my attention which gives me cause to believe that:
- 1 accounting records were not kept in accordance with section 386 of the Companies Act 2006; or
- 2 the accounts do not accord with such records; or
- 3 the accounts do not comply with relevant accounting requirements under section 396 of the Companies Act 2006 other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or
- 4 the accounts have not been prepared in accordance with the Charities SORP (FRS102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
## **Arvind Joshi FCA CTA DChA**
## **Independent examiner**
Levy + Partners Limited Chartered Accountants 7-8 Ritz Parade Western Avenue London W5 3RA
Date: 10 September 2025
**Page 5**
## **Centre for Research and Implementation of Clinical Practice**
## **(A company limited by guarantee)**
## **Statement of financial activities (incorporating the income and expenditure account)**
## **For the year ended 30 March 2025**
|**Unrestricted**
**funds**
**Notes**
**£**
**Income**
Research
30,385
Bank interest received
45
**Total income**
30,430
**Expenditure**
Research costs
2
14,016
Governance costs
3
12,879
**Total expenditure**
26,895
**Net movement in funds**
3,535
Total funds brought forward
553
**Total funds carried forward**
4,088|**2025**
**Total**
**£**
30,385
45
30,430
14,016
12,879
26,895
3,535
553
4,088|**2024**
**Total**
**£**
35,694
360
36,054
33,580
36,370
69,950
)
(33,896
34,449
553|
|---|---|---|
All of the above amounts relate to continuing activities. There are no restricted funds.
There are no recognised gains or losses other than the surplus or deficit for the above two financial years.
**The notes on pages 9 to 11 form an integral part of these financial statements.**
**Page 6**
## **Centre for Research and Implementation of Clinical Practice**
## **(A company limited by guarantee)**
## **Balance sheet as at 30 March 2025**
|**Notes**
**Current assets**
Cash at bank and in hand
**Creditors: amounts falling**
**due within one year**
6
**Net current assets**
**Net assets**
**Funds of the charity**
Unrestricted funds
7
**Total charity funds**|**2025**
**£**
**£**
13,612
13,612
)
(9,524
4,088
4,088
4,088
4,088|**2024**
**£**
**£**
9,098
9,098
)
(8,545
553
553
553
553|**2024**
**£**
**£**
9,098
9,098
)
(8,545
553
553
553
553|
|---|---|---|---|
||||553|
||||553|
||||553|
The Balance Sheet continues on the following page.
**The notes on pages 9 to 11 form an integral part of these financial statements.**
**Page 7**
## **Centre for Research and Implementation of Clinical Practice (A company limited by guarantee)**
## **Balance sheet (continued)**
## **Trustees' (directors) statements required by the Companies Act 2006 for the year ended 30 March 2025**
In approving these financial statements as trustees (directors) of the charitable company, we hereby confirm:
that for the year stated above the charitable company was entitled to the exemption from an audit under section 477 of the Companies Act 2006.
The members have not required the charitable company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Act.
The trustees/directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements were approved by the board on 10 September 2025 and signed on its behalf by
## P J Franks **Trustee (Director)**
_Company number: 02949804_
**The notes on pages 9 to 11 form an integral part of these financial statements.**
**Page 8**
**Centre for Research and Implementation of Clinical Practice**
## **(A company limited by guarantee)**
## **Notes to financial statements for the year ended 30 March 2025**
## **1. Statement of compliance**
The principal accounting policies are summarised below. The accounting policies have been applied consistently throughout the year and the preceding year.
## **1.1. Basis of accounting**
The financial statements have been prepared under the historical cost convention and in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015)' and the Companies Act 2006 as it applies from 1 January 2015. The charity is a Public Benefit Entity as defined by FRS 102.
## **1.2. Income**
All incoming resources are included in the statement of financial activities when the charity is entitled to the income and the amount can be quantified with reasonable accuracy.
Income from investments is included in the year in which it is receivable.
## **1.3. Expenditure**
Expenditure is recognised in the period in which the expenditure is incurred. Expenditure includes any VAT which cannot be fully recovered, and is reported as part of the expenditure to which it relates.
Charitable expenditure comprises those costs incurred by the charitable company in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.
Support costs are those costs incurred directly in support of expenditure on the objects of the charity and include project management.
## **1.4. Research and development**
Research expenditure is written off to the surplus/(deficit) account in the year in which it is incurred.
## **2. Costs of charitable activities**
|**Unrestricted**
**funds**
**£**
Wages & Salaries
14,016
14,016|**2025**
**Total**
**£**
14,016
14,016|**2024**
**Total**
**£**
33,580|
|---|---|---|
|||33,580|
**Page 9**
**Centre for Research and Implementation of Clinical Practice**
## **(A company limited by guarantee)**
## **Notes to financial statements for the year ended 30 March 2025**
## **3. Governance costs**
|**Governance costs**|||
|---|---|---|
|**Unrestricted**
**funds**
**£**
Accountancy fees
1,224
Insurance
1,680
Professional
335
Office costs
1,541
General expenses
89
Bank charges
77
Research & development costs
7,933
12,879
**Employees**
**Employment costs**
Wages and salaries
No employee received emoluments of more than £60,000 (2024 : None).|**2025**
**Total**
**£**
1,224
1,680
335
1,541
89
77
7,933
12,879
**2025**
**£**
14,016|**2024**
**Total**
**£**
1,224
3,000
-
352
173
102
31,519|
|||36,370|
|||**2024**
**£**
33,580|
||||
## **4. Employees**
## **Number of employees**
The average monthly numbers of employees (including the trustees) during the year, calculated on the basis of full time equivalents, was as follows:
|**2025**|**2024**|
|---|---|
|**Number**|**Number**|
|1.2|1.2|
## **5. Taxation**
The company is exempt from tax on its charitable activities as it is a registered charity.
**Page 10**
**Centre for Research and Implementation of Clinical Practice**
## **(A company limited by guarantee)**
## **Notes to financial statements for the year ended 30 March 2025**
## **6. Creditors: amounts falling due within one year**
|**Creditors: amounts falling due**|||||
|---|---|---|---|---|
|**within one year**|||**2025**|**2024**|
||||**£**|**£**|
|Other creditors|||7,156|7,156|
|Other taxes and social security|||200|21|
|Wages and salaries|||800|-|
|Accruals|||1,368|1,368|
||||9,524|8,545|
|**Unrestricted funds**|**At**|||**At**|
||**1 April**|**Incoming**|**Outgoing**|**31 March**|
||**2024**|**resources**|**resources**|**2025**|
||**£**|**£**|**£**|**£**|
|Unrestricted Funds|553|30,430|)
(26,895|4,088|
## **7. Unrestricted funds**
## **8. Related party transactions**
There were no related party transaction.
## **9. Going concern**
The financial statements have been prepared on the assumption that the charitable company is able to carry on operations as a going concern, which the directors consider appropriate having regard to the circumstances.
## **10. Company limited by guarantee**
Centre for Research and Implementation of Clinical Practice is a company limited by guarantee and accordingly does not have a share capital.
The directors as members of the company, undertake to contribute such amount as may be required not exceeding £1 to the assets of the charitable company in the event of its being wound up while he or she is a member, or within one year after he or she ceases to be a member.
**Page 11**